MBP metabolic pharmaceuticals limited

Off 10% after company update cited some slight delay in clinical...

  1. 729 Posts.
    Off 10% after company update cited some slight delay in clinical trials sign-up procedure and therefore results delayed till Q4 instead of Q3 2004.

    IMO presented a buying opportunity as the impatient passed their shares to the patient

    Topped up @ 80. R/B
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.